Endometrium News and Research

RSS
Merck's NEXPLANON 68 mg now available in the U.S.

Merck's NEXPLANON 68 mg now available in the U.S.

Raised blood pressure may higher risk of cancer, death

Raised blood pressure may higher risk of cancer, death

Uterine stem cells could help treat diabetes

Uterine stem cells could help treat diabetes

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

Positive data from Aeterna Zentaris' AEZS-108 Phase 2 study on advanced endometrial cancer

First report of alternative lengthening of telomeres in human cancer subtypes

First report of alternative lengthening of telomeres in human cancer subtypes

Taller women more prone to cancer: Study

Taller women more prone to cancer: Study

Hysterectomy procedures will continue to decline due to advantages of less-invasive alternatives: MRG

Hysterectomy procedures will continue to decline due to advantages of less-invasive alternatives: MRG

New computer-based system can distinguish similar secondary tumours

New computer-based system can distinguish similar secondary tumours

Routine sonograms after IUD insertion can reduce pregnancy complications

Routine sonograms after IUD insertion can reduce pregnancy complications

Leading cancer center to acquire GammaMed brachytherapy from Varian

Leading cancer center to acquire GammaMed brachytherapy from Varian

G-CSF treatment improves inadequate endometrium during IVF cycles

G-CSF treatment improves inadequate endometrium during IVF cycles

American Cancer Society reports racial disparity continues to increase death rate for some cancers

American Cancer Society reports racial disparity continues to increase death rate for some cancers

Aeterna presents data on AEZS-108 Phase 2 study for endometrial cancer at EORTC-NCI-AACR Symposium

Aeterna presents data on AEZS-108 Phase 2 study for endometrial cancer at EORTC-NCI-AACR Symposium

Can Pfizer rescue hormonal replacement therapy?

Can Pfizer rescue hormonal replacement therapy?

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Ferring Pharmaceuticals announces publication of Phase 3 trials of LYSTEDA tablets for HMB

Intrauterine devices for treatment of endometrial cancer

Intrauterine devices for treatment of endometrial cancer

Babies born after IVM fertility treatment more likely to be born larger than normal

Babies born after IVM fertility treatment more likely to be born larger than normal

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

UPA: An effective non-invasive treatment for fibroids can help maintain fertility in women

Diabetes associated with increased risk of cancer

Diabetes associated with increased risk of cancer

Study highlights benefits of using endometrial stem cells to restore functioning of brain cells

Study highlights benefits of using endometrial stem cells to restore functioning of brain cells